Try our beta test site
Trial record 1 of 1 for:    NCT00910962
Previous Study | Return to List | Next Study

A Study to Evaluate the Safety of 12 Weeks of Dosing With GW856553 and Its Effects on Inflammatory Markers, Infarct Size, and Cardiac Function in Subjects With Myocardial Infarction Without ST-segment Elevation (Solstice)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00910962
First received: May 28, 2009
Last updated: January 27, 2017
Last verified: January 2017